Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma.
Yanhong ChuLingyu QianYaohua KeXiaoyu FengXinjie ChenFangcen LiuLixia YuLianru ZhangYaping TaoRui XuJia WeiBaorui LiuQin LiuPublished in: Journal of nanobiotechnology (2022)
We developed a general vaccine strategy, triggering specific T cell responses, and provided feasible combination strategies for better anti-tumor efficacy.